Table 6.

Correlation of SOCS members with OC patients receiving different chemotherapy regimes

Gene	Chemotherapy	Case-low1	Case-high2	HR (95% CI)	p-value
SOCS1	contains platin	505	904	0.84 (0.73-0.97)	0.017*
	contains taxol	318	475	0.71 (0.59-0.86)	0.00037**
SOCS2	contains platin	262	216	1.3 (1.03-1.64)	0.026*
	contains taxol	198	159	1.24 (0.94-1.66)	0.13
SOCS3	contains platin	287	191	1.24 (0.98-1.57)	0.07
	contains taxol	221	136	1.22 (0.91-1.63)	0.19
SOCS4	contains platin	260	218	0.89 (0.71-1.13)	0.33
	contains taxol	198	159	0.82 (0.61-1.09)	0.17
SOCS5	contains platin	679	730	1.41 (1.22-1.62)	1.8e-06**
	contains taxol	416	377	1.48 (1.23-1.79)	3.5e-05**
SOCS6	contains platin	125	353	1.15 (0.88-1.5)	0.3
	contains taxol	239	118	0.79 (0.57-1.09)	0.15
SOCS7	contains platin	269	209	1.33 (1.05-1.67)	0.016*
	contains taxol	239	118	1.38 (1.03-1.85)	0.03*
CIS	contains platin	353	125	1.32 (1.03-1.69)	0.03*
	contains taxol	267	90	1.31 (0.96-1.79)	0.091

¹Cases-low: patient number-low expression of the corresponding gene.

²Cases-high: patient number-high expression of the corresponding gene.

^* P < 0.05;

^** P < 0.01.